Read about my view on late side effects after modern radiotherapy for Hodgkin lymphoma. Much progress since the days of mantle therapy. Don’t abandon radiotherapy at the cost of more relapses. medicaljournalssweden.se/actaoncologi...

HD21, BrECADD for Hodgkin patients >60 years. PFS 91.5% at 2 years. We use mostly N-AVD for these patients but BrECADD can be an effective alternative for fit patients, with shorter treatment duration and less doxorubicine. ascopubs.org/doi/10.1200/...

Fertility data from HD21, just published. Compared with eBEACOPP, BrECADD led to better gonadal recovery and higher parenthood rates. Support BrECADD as preferred first-line treatment for younger pts with advanced Hodgkin lymphoma. www.sciencedirect.com/science/arti...

6x Nivo-AVD with PFS & OS benefit and better tolerability vs 6x BV-AVD in AS-HL pts ≥60 years in the randomised S1826 trial. Efficacy driven by EBV status? PRO-CTCAE confirming better tolerability & revealing discrepancy to physician reporting @ascocancer.bsky.social ascopubs.org/doi/10.1200/...

The Swedish lymphoma group’s annual conference. Always a pleasure.

Here we introduce a simple 3-point frailty score for older Hodgkin patients to inform clinical decisions and prospective trials. Published today! haematologica.org/haematologic...

Speaker at the annual course in lymphatic malignancies, together with lymphoma experts from many parts of Sweden.

Meeting with the Swedish Hodgkin lymphoma group. Always a pleasure!

Brentuximab Vedin for older frail patients with Hodgkin lymphoma. One of the arms of the BVB-trial now published. A fruitful collaboration between the Nordic lymphoma group and the German Hodgkin study group. onlinelibrary.wiley.com/share/XSFFTV...

A woman with multiply relapsed multiple myeloma had complete remission with cilta-cel, but a low-grade T-cell lymphoma soon developed in the GI tract that contained an insertion of the CAR construct disrupting expression of p53. Read the Brief Report: nej.md/40Yq3gO #MedSky #Oncology

HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal. Antiinflammatory agents, etoposide, and interferon-γ antibody are the main treatments. Learn more in a new review: nej.md/40Jps19 #MedSky #Oncology

Speaking at the UK Hodgkin lymphoma forum. Excellent meeting. Thank you for the nice invitation Graham Collins and colleagues!